EGFR-Targeted Therapy Alters the Tumor Microenvironment In EGFR-Driven Lung Tumors: Rationale for Combination Therapies

被引：0
|
作者：
Jia, Y. [1 ]
Jiang, T. [1 ]
Li, X. [1 ]
Zhao, C. [1 ]
Zhou, C. [1 ]
Zhao, S. [1 ]
机构：
[1] Tongji Univ, Shanghai Pulm Hosp, Sch Med, Dept Med Oncol, Shanghai, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2018年 / 13卷 / 10期
关键词：
lung cancer; EGFR-TKI; tumor microenvironment;
D O I：
10.1016/j.jtho.2018.08.554
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MA27.10
引用
收藏
页码：S457 / S457
页数：1
相关论文
共 50 条
  • [21] Tumor genotype dependency of checkpoint blockade therapy in EGFR-driven glioblastoma.
    Yeo, Alan T.
    Charest, Alain
    CANCER IMMUNOLOGY RESEARCH, 2020, 8 (03) : 93 - 93
  • [22] EGFR-Targeted Therapy for Non-Small Cell Lung Cancer: Focus on EGFR Oncogenic Mutation
    Antonicelli, Alberto
    Cafarotti, Stefano
    Indini, Alice
    Galli, Alessio
    Russo, Andrea
    Cesario, Alfredo
    Lococo, Filippo Maria
    Russo, Patrizia
    Mainini, Alberto Franco
    Bonifati, Luca Giuseppe
    Nosotti, Mario
    Santambrogio, Luigi
    Margaritora, Stefano
    Granone, Pierluigi Maria
    Dutly, Andre Emanuel
    INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2013, 10 (03): : 320 - 330
  • [23] Cellular Origins of EGFR-Driven Lung Cancer Cells Determine Sensitivity to Therapy
    Chen, Fan
    Liu, Jinpeng
    Flight, Robert M.
    Naughton, Kassandra J.
    Lukyanchuk, Alexsandr
    Edgin, Abigail R.
    Song, Xiulong
    Zhang, Haikuo
    Wong, Kwok-Kin
    Moseley, Hunter N. B.
    Wang, Chi
    Brainson, Christine F.
    ADVANCED SCIENCE, 2021, 8 (22)
  • [24] Non-small cell lung cancer: an update on emerging EGFR-targeted therapies
    Favorito, Valentina
    Ricciotti, Ilaria
    De Giglio, Andrea
    Fabbri, Laura
    Seminerio, Renata
    Di Federico, Alessandro
    Gariazzo, Eleonora
    Costabile, Silvia
    Metro, Giulio
    EXPERT OPINION ON EMERGING DRUGS, 2024, 29 (02) : 139 - 154
  • [25] The tumor microenvironment in EGFR-driven loco-regional lung adenocarcinoma can predict higher risk of recurrence.
    Khalil, Maya
    Elkhanany, Ahmed
    Yang, Yuanquan
    Glenn, Sean
    Papanicolau-Sengos, Antonios
    Morrison, Carl
    Dy, Grace K.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [26] Tumor heterogeneity and resistance to EGFR-targeted therapy in advanced nonsmall cell lung cancer: challenges and perspectives
    Cheng, Xinghua
    Chen, Haiquan
    ONCOTARGETS AND THERAPY, 2014, 7 : 1689 - 1704
  • [27] Activation of the AXL kinase causes resistance to EGFR-targeted therapy in lung cancer
    Zhang, Zhenfeng
    Lee, Jae Cheol
    Lin, Luping
    Olivas, Victor
    Au, Valerie
    LaFramboise, Thomas
    Abdel-Rahman, Mohamed
    Wang, Xiaoqi
    Levine, Alan D.
    Rho, Jin Kyung
    Choi, Yun Jung
    Choi, Chang-Min
    Kim, Sang-We
    Jang, Se Jin
    Park, Young Soo
    Kim, Woo Sung
    Lee, Dae Ho
    Lee, Jung-Shin
    Miller, Vincent A.
    Arcila, Maria
    Ladanyi, Marc
    Moonsamy, Philicia
    Sawyers, Charles
    Boggon, Titus J.
    Ma, Patrick C.
    Costa, Carlota
    Taron, Miquel
    Rosell, Rafael
    Halmos, Balazs
    Bivona, Trever G.
    NATURE GENETICS, 2012, 44 (08) : 852 - +
  • [28] IL-17A induces EGFR-targeted therapy resistance via enhancing EGFR activation in lung cancer
    Lee, Kai Ling
    Chung, Chi-Li
    Chien, Ming-Hsien
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [29] Activation of the AXL kinase causes resistance to EGFR-targeted therapy in lung cancer
    Zhenfeng Zhang
    Jae Cheol Lee
    Luping Lin
    Victor Olivas
    Valerie Au
    Thomas LaFramboise
    Mohamed Abdel-Rahman
    Xiaoqi Wang
    Alan D Levine
    Jin Kyung Rho
    Yun Jung Choi
    Chang-Min Choi
    Sang-We Kim
    Se Jin Jang
    Young Soo Park
    Woo Sung Kim
    Dae Ho Lee
    Jung-Shin Lee
    Vincent A Miller
    Maria Arcila
    Marc Ladanyi
    Philicia Moonsamy
    Charles Sawyers
    Titus J Boggon
    Patrick C Ma
    Carlota Costa
    Miquel Taron
    Rafael Rosell
    Balazs Halmos
    Trever G Bivona
    Nature Genetics, 2012, 44 : 852 - 860
  • [30] Mechanisms of resistance to egfr-targeted therapy induced by nicotine in human lung cancer
    Extremera Mazuela, Maria
    Bordas Sanchez, Anna
    Montiel Lopez, Carmen
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2019, 125 : 30 - 30
12345